144 related articles for article (PubMed ID: 8364914)
1. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors.
Nees M; Homann N; Discher H; Andl T; Enders C; Herold-Mende C; Schuhmann A; Bosch FX
Cancer Res; 1993 Sep; 53(18):4189-96. PubMed ID: 8364914
[TBL] [Abstract][Full Text] [Related]
2. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
Brachman DG; Graves D; Vokes E; Beckett M; Haraf D; Montag A; Dunphy E; Mick R; Yandell D; Weichselbaum RR
Cancer Res; 1992 Sep; 52(17):4832-6. PubMed ID: 1324797
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX
Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882
[TBL] [Abstract][Full Text] [Related]
5. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
6. p53 expression and mutations in squamous cell carcinoma of the head and neck: expression correlates with the patients' use of tobacco and alcohol.
Field JK; Zoumpourlis V; Spandidos DA; Jones AS
Cancer Detect Prev; 1994; 18(3):197-208. PubMed ID: 8076382
[TBL] [Abstract][Full Text] [Related]
7. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
[TBL] [Abstract][Full Text] [Related]
8. Analysis of p53 antibody response in patients with squamous cell carcinoma of the head and neck.
Lavieille JP; Lubin R; Soussi T; Reyt E; Brambilla C; Riva C
Anticancer Res; 1996; 16(4C):2385-8. PubMed ID: 8816839
[TBL] [Abstract][Full Text] [Related]
9. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
10. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis.
Shin DM; Kim J; Ro JY; Hittelman J; Roth JA; Hong WK; Hittelman WN
Cancer Res; 1994 Jan; 54(2):321-6. PubMed ID: 8275461
[TBL] [Abstract][Full Text] [Related]
11. Frequent p53 mutations in head and neck cancer.
Somers KD; Merrick MA; Lopez ME; Incognito LS; Schechter GL; Casey G
Cancer Res; 1992 Nov; 52(21):5997-6000. PubMed ID: 1394225
[TBL] [Abstract][Full Text] [Related]
12. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
[TBL] [Abstract][Full Text] [Related]
13. p53 alterations in chemically induced hamster cheek-pouch lesions.
Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
[TBL] [Abstract][Full Text] [Related]
14. p53-positive tumor-distant squamous epithelia of the head and neck reveal selective loss of chromosome 17.
Wolf C; Flechtenmacher C; Dietz A; Weidauer H; Abel U; Maier H; Bosch FX
Laryngoscope; 2004 Apr; 114(4):698-704. PubMed ID: 15064627
[TBL] [Abstract][Full Text] [Related]
15. [Significance of aberrant p53 protein in head-neck tumors and its effect on proliferation and differentiation].
Homann N; Andl T; Nees M; Schuhmann A; Herold-Mende C; Bosch FX
HNO; 1993 May; 41(5):254-60. PubMed ID: 8392993
[TBL] [Abstract][Full Text] [Related]
16. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
17. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations and histological type of invasive breast carcinoma.
Marchetti A; Buttitta F; Pellegrini S; Campani D; Diella F; Cecchetti D; Callahan R; Bistocchi M
Cancer Res; 1993 Oct; 53(19):4665-9. PubMed ID: 8402644
[TBL] [Abstract][Full Text] [Related]
19. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
[TBL] [Abstract][Full Text] [Related]
20. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT
Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]